Pre-diagnostic Changes in the Metabolome of Inflammatory Bowel Disease

Key Points

• Metabolomic shifts indicate potential biomarkers for inflammatory bowel disease diagnosis.
• Key evidence shows significant changes in lipid metabolism markers during the pre-diagnostic period.
• Analysis reveals early metabolic alterations linked to inflammatory bowel disease progression.
• Findings highlight the need for further research to establish causal relationships and validate biomarkers.